Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Change in Inventory (2023 - 2025)

Bioharvest Sciences has reported Change in Inventory over the past 3 years, most recently at $1.7 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 11.93% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $904000.0, down 23.97%, while the annual FY2025 figure was $904000.0, 23.97% down from the prior year.
  • Change in Inventory was $1.7 million for Q4 2025 at Bioharvest Sciences, up from -$307000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.9 million in Q4 2024 and bottomed at -$620000.0 in Q3 2024.
  • The 3-year median for Change in Inventory is -$162500.0 (2024), against an average of $162000.0.
  • The widest YoY moves for Change in Inventory: up 588.75% in 2024, down 656.1% in 2024.
  • Over 3 years, Change in Inventory stood at -$391000.0 in 2023, then soared by 588.75% to $1.9 million in 2024, then decreased by 11.93% to $1.7 million in 2025.
  • The last three reported values for Change in Inventory were $1.7 million (Q4 2025), -$307000.0 (Q3 2025), and -$115000.0 (Q2 2025) per Business Quant data.